Objective: The d2 Test of Attention (D2) is a commonly used measure of selective attention for patients with schizophrenia. However, its test-retest reliability and minimal detectable change (MDC) are unknown in patients with schizophrenia, limiting its utility in both clinical and research settings. The aim of the present study was to examine the test-retest reliability and MDC of the D2 in patients with schizophrenia. Method: A rater administered the D2 on 108 patients with schizophrenia twice at a 1-month interval. Test-retest reliability was determined through the calculation of the intra-class correlation coefficient (ICC). We also carried out Bland-Altman analysis, which included a scatter plot of the differences between test and retest against their mean. Systematic biases were evaluated by use of a paired t-test. Results: The ICCs for the D2 ranged from 0.78 to 0.94. The MDCs (MDC%) of the seven subscores were 102
Introduction
Among the variety of cognitive deficits in schizophrenia, the most robust is deficits of attention (Elvevag & Goldberg, 2000; Nuechterlein et al., 2004) . Selective attention refers to the ability to maintain a behavioral or cognitive set in the face of distracting or competing stimuli (Biehl et al., 2013; Lavie, 2005) . It thus incorporates the notion of freedom from distractibility (Sohlberg & Mateer, 2001b) . Individuals with selective attention deficits are easily drawn off task by extraneous, irrelevant stimuli (Smith & Lilienfeld, 2015) . Examples of problems include an inability to perform therapy tasks in a stimulating environment (e.g., an open treatment area) or to prepare a meal with children playing in the background (Sohlberg & Mateer, 2001a) . Therefore, the selective attention function is measured periodically to detect and monitor the attention status of patients with schizophrenia in clinical settings. For reliable measurements, a measurement for assessing selective attention with sound reliability is needed.
Test-retest reliability is the highest-rated test criterion among surveyed experts because this property is critical for detecting changes with treatment of schizophrenia . Intra-class correlation (ICC) methods have been commonly used for assessing test-retest reliability in recent studies (Brennan & Silman, 1992) . The ICC reflects both the degree of correlation and level of agreement between measures (Lee, Li, Liu, & Hsieh, 2011) , and the ICC is also widely accepted to better represent the reliability of a measure than a value of Pearson's r (Brennan & Silman, 1992; Patten, Kothari, Whitney, Lexell, & Lum, 2003; Prince, Makrides, & Richman, 1980; Shrout & Fleiss, 1979) . In addition, to determine whether a change score between repeated measurements is significant, researchers need to provide minimal detectable change (MDC) scores for users to interpret the results of repeated measurements (Goldsmith, Boers, Bombardier, & Tugwell, 1993; Schuck & Christian, 2003; Steffen & Seney, 2008) . The MDC is defined as the minimum amount of change that is not due to variation in measurement (Schreuders et al., 2003) . Namely, when a difference between two successive measurements exceeds the MDC, the change is more likely to be viewed as a real difference, rather than merely random error (Michon, Kroon, Van Weeghel, & Schene, 2004) . Once the MDC is determined on a particular test for a given population, clinicians can interpret whether the change scores of their patients are at or above the minimal level of detectable change (Ries, Echternach, Nof, & Gagnon, 2009; Wagner, Rhodes, & Patten, 2008) . Thus, the MDC is crucial for clinicians and researchers to determine real change in repeated measurements for an individual patient (Kovacs et al., 2008) .
The d2 Test of Attention (D2), a cancellation test, is a user-friendly and valid measure of selective attention often used in related research for patients with schizophrenia (Boyer et al., 2013 (Boyer et al., , 2014 Brickenkamp & Zillmer, 1998; Ernst, Haugaard, Olrik, Munk-Jorgensen, & Ostergaard, 2013; Rehse et al., 2016) . The D2 is used because it is low in cost, easy and fast to administer, and applicable to testing large numbers of people simultaneously (Van den Berg et al., 2016) . The D2 assesses performance in terms of visual perceptual speed and concentrative capacities by assessing an individual's ability to selectively, quickly, and accurately focus on certain relevant aspects in a task while ignoring irrelevant aspects (Vanhelst et al., 2016) .
In terms of reliability, the D2 has good test-retest reliability in a normal adult sample (Brickenkamp & Zillmer, 1998) . However, the test-retest reliability and MDC of the D2 have been examined little in patients with schizophrenia, limiting the interpretability and applicability of this measure for research and clinical settings. Thus, the purpose of our study was to examine the test-retest reliability and MDC of the D2 in patients with schizophrenia.
Methods

Participants
Participants were recruited from a clinical psychiatric hospital, and all were Taiwanese. Participants with the following characteristics were included: (A) diagnosis of schizophrenia according to the International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM) diagnostic criteria; (B) clinical stability with a stable dose of antipsychotic medication for at least 3 months prior to the study; (C) sufficient reading or listening comprehension to complete the D2 (Mini Mental State Examination [MMSE] score > 24); (D) absence of substance abuse, severe medical or neurological condition, or other psychiatric disorder that required treatment (e.g., mental retardation, dementia, or developmental disability); (E) age 20-65 years; and (F) provision of informed consent. Criterion (B) was used to support the assumption for examining testretest reliability (i.e., the attention performance of participants was assumed to be stable between two measurements).
Participants were excluded from the study if they: (A) were participating in another clinical trial; (B) were suffering an episode of major depression; and/or (C) exhibited difficulties in recognizing the letters of the English alphabet. The study protocol was reviewed and approved by the Institutional Review Board of the study hospital.
Originally, a total of 150 participants were approached for recruitment in the study, and 33 of them did not meet the criteria. In the end, 117 participants who were eligible for the study were recruited. Of these, 11 participants did not complete the second session because they were discharged from the hospital, withdrew, or were otherwise lost to follow-up. Thus, the final sample included 106 participants. Participants completed the test within about 8 min. All participants confirmed that they had continued with their regular therapeutic activities during the study periods.
Research Procedure
The D2 was administered to the participants by a specially trained occupational therapist twice, at an interval of 1 month. The occupational therapist was trained specifically to administer the D2 test. The test was administered in a quiet room with no environmental distractions. Participants' demographic data were collected from medical records. The psychopathological stability of the participants with schizophrenia was assessed with the Clinical Global Impression-Severity (CGI-S) (Guy, 1976) .
The participants with stable CGI-S (i.e., the CGI-S category was exactly the same at the two time points) were included for further analysis. The CGI-S was administered by the same rater. The participants continued with their regular therapeutic activities during the study periods.
Measures
The D2 is a one-page paper-and-pencil test for selective attention. The standard version of the D2 consists of 14 rows (trials), each with 47 randomly mixed "p" and "d" letters (Brickenkamp & Zillmer, 1998) , for a total of 658 letters. The target symbol is a "d" with two dashes (hence "d2"). The participant's task is to cancel out as many target symbols as possible, moving from left to right, with a time limit of 20 s/trial. The seven subscores of the D2 are total number (TN), omissions (E 1 ), commissions (E 2 ), errors (E), total-errors (TN-E), concentration performance (CP), and fluctuation rate (FR). TN is a quantitative measure of performance of all items that were processed. E 1 occurs when relevant items ("d" with two dashes) are not crossed out. E 2 occurs when irrelevant letters are crossed out in violation of the instructions. The raw score E is the sum of all mistakes. TN-E is the total number of items scanned minus error scores (E). CP is derived from the number of the correctly crossed out relevant items minus the E 2 . FR is the difference between the line (or lines) with the minimum numbers of items processed (Brickenkamp & Zillmer, 1998) .
The coefficients of test-retest reliability are good for adults at an interval of less than 3 months (r = 0.90). The results of adults are more stable than those of children or adolescents over a longer period. Regarding the validity of the D2, the highest relationship is with the symbol digit modalities test (SDMT). In order to examine the construct validity, a factor analysis was calculated for the D2. The results further supported the sensitivity of the D2 as a test of concentration and attention. Therefore, the construct and convergent validity of the D2 are good for assessing attention (Bates & Lemay, 2004) . The D2 is a reliable and valid measurement tool.
The CGI-S is commonly used for assessing symptom severity in schizophrenia research and clinical practice (Busner & Targum, 2007) . The scale is a 1-item observer-rated scale and clinician-rated instrument (Guy, 1976) . The CGI-S is a 7-point scale for rating the severity of psychiatric illness (Huang et al. 2012) . The clinicians rate the severity of the patient's mental illness at the time of measurement (1 = not at all, 2 = borderline, 3 = mild, 4 = moderate, 5 = marked, 6 = severe, and 7 = extremely ill) (Otto et al., 2010) . The inter-rater reliability has an ICC of 0.75 (Haro et al., 2003) . The content validity of the CGI-S is strong (Allen et al., 2012) . The CGI-S was used to assess the change in clinical status of the participants (Leucht, Davis, Engel, Kissling, & Kane, 2009; Patrick et al., 2009; Wu et al., 2013) .
Statistical Analysis
Data were analyzed in the Statistical Package for Social Science version 22.0 (SPSS Inc., Chicago, IL). The alpha level was set at 0.05 for all statistical tests, and all p-values were two tailed.
Test-Retest Reliability
Test-retest reliability was determined through calculation of the ICC (2,1) , a two-way random-effects single-measure reliability (absolute agreement) (Rankin & Stokes, 1998; Shrout & Fleiss, 1979) . The ICC is the ratio of the inter-subject component of variance (inter-subject variance + within-subject variance) (Prince et al. 1980) . There is no universally agreed level for ICC values in relation to levels of reliability, but the following scheme has been previously reported as acceptable: 0.90-0.99, excellent reliability; 0.80-0.89, good reliability; 0.70-0.79, fair reliability; 0.69 or below, poor reliability (Arnall, Koumantakis, Oldham, & Cooper, 2002) . The ICCs of the D2 were computed for the test and retest sessions (Haley & Fragala-Pinkham, 2006) .
Minimal Detectable Change (MDC) and MDC Percentage (MDC%)
The MDC was calculated based on the standard error of measurement (SEM) according to the equations below (Michon et al. 2004 ):
In these formulas, 1.96 is the z-score at the 95% confidence level, √2 is used because of the underlying extra uncertainty during measurement at two time points, and r is the coefficient of the test-retest reliability, which was represented by the ICC. In addition, we calculated the MDC% (=MDC/mean × 100%), which presents the relative amount of random measurement error. The "mean" in this equation is the mean score of all trials. An MDC% of 30% or less is considered acceptable, and one of 10% or less, excellent (Smidt et al., 2002) .
Systematic Bias
We used a paired t-test to examine whether systematic biases existed. The differences between the test-retest assessments were considered significant if p-values were smaller than .05. We also calculated the effect size, which was the mean changes divided by the standard deviation of the first session scores, to determine the extent of bias (Kazis, Anderson, & Meenan, 1989) . According to Cohen's criteria, an effect size of greater than 0.8 was considered large; 0.5-0.8, moderate; and 0.2-0.5, small (Cohen, Nordahl, Semple, Andreason, & Pickar, 1998 ).
Bland-Altman Plots
Bland-Altman plots were used to visually examine the agreement of a test by plotting the difference scores against the mean score of each pair of measurements (Bland & Altman, 1986) . Assuming the differences follow normal distribution, 95% of the differences (limits of agreement, LOA) should lie between d ± 1.96 × SD, where d represents the mean difference between test and retest scores, and SD is the standard deviation of differences of each pair (Bland & Altman, 2003; Liaw et al., 2008) . The plot shows the difference between test sessions 2 and 1 (2-1) against the mean of the two test sessions for each subject (Bland & Altman, 2003) .
Heteroscedasticity
In addition, we used Pearson's r to examine the association between the absolute difference and the mean of each pair of repeated measurements to examine the possibility of heteroscedasticity, meaning that a systematic trend (e.g., the higher the scores, the larger the differences) exists. If heteroscedasticity exists, the MDC should not be applied for different levels (e.g., attention deficits in this study) of patients. According to Atkinson's suggestion, if the absolute value of Pearson's r is greater than 0.3, the data are heteroscedastic (Atkinson & Nevill, 1998) .
Results
Demographic and Clinical Characteristics of Participants
All of these participants had the same CGI-S category at both sessions. Their CGI-S scores were mostly mild (40.6%) or borderline (31.1%). Table 1 displays demographic data for the 106 participants. The mean age was approximately 44 years old (SD = 8.9), and 56.6% of the participants were male. All participants were receiving maintenance medication, taking antipsychotic medication alone (the three most common medications were haloperidol, clozapine, and sulpiride), and there were no significant changes in medication in the 1-month study period.
Test-Retest Reliability
The reliability indices of the D2 are listed in Table 2 . The ICCs for the seven subscores of the D2 between successive sessions were between 0.78 and 0.94. The paired t-test showed that all the subscores were significantly different. The effect sizes were 0.07, 0.04, 0.03, 0.05, 0.07, 0.08, and 0.06 for the TN, E 1 , E 2 , E, TN-E, CP, and FR, respectively.
Minimal Detectable Change (MDC)
The MDCs of the subscores of the D2 were 102.3, 19.4, 7.2, 21.0, 104.0, 105.0, and 7.8 for the TN, E 1 , E 2 , E, TN-E, CP, and FR, respectively. All MDC% of the seven subscores were between 29.7% and 94.6%. Seven Bland-Altman plots (Fig. 1 ) that were representative of the D2 showed the LOA ranges to be −95.6 to 113.8, −20.2 to 18.8, −7.5 to 7.0, −22.0 to 20.2, −96.4 to 116.3, −89.1 to 113.5, and −8.1 to 7.4 for the TN, E 1 , E 2 , E, TN-E, CP, and FR, respectively. In addition, trends in the plots of the E 1 , E 2 , and E were noted (Pearson's r were 0.37, 0.62, and 0.33, respectively).
Discussion
The study first examined the D2 by assessing the test-retest reliability and MDC for persons with schizophrenia. We found that the ICC values of the D2 were fair to excellent. For the repeated uses of the D2, the scores of TN (0.93), TN-E (0.93), and CP (0.94) were found to be more reliable than E 1 (0.82), E 2 (0.88), E (0.85), and FR (0.78). In the published D2 manual, test-retest reliability is reported from the samples of 38 children, 37 adolescents, and 31 adults (Brickenkamp & Zillmer, 1998) . The test-retest interval was approximately 3 months, and the Pearson coefficients ranged from 0.72 to 0.90 for TN-E. These results were close to ours, implying that the test-retest reliability of the D2 in persons with schizophrenia is not clearly different from that in the aforementioned samples. However, it is suggested that clinicians and researchers who use the D2 to assess patients with schizophrenia should take into account the fair agreement between test and retest sections, especially in the FR indices. On the other hand, the ICC values of TN, TN-E, and CP indices in the current study, which ranged from 0.93 (TN and TN-E) to 0.94 (CP), indicate that the D2 has excellent reliability in patients with schizophrenia.
Systematic bias, which may result from the practice effect, was noted in the subscores (TN, TN-E, and CP), a fact that may affect the accuracy of our findings. Fortunately, the effect sizes of the TN, TN-E, and CP subscales were small. Notes: SD = standard deviation; CGI-S = Clinical Global Impression-Severity. Notes: TN = total number; E 1 = Omissions; E 2 = Commissions; E = errors; TNE = total-errors; CP = concentration performance; FR = fluctuation rate. Therefore, for the scores of TN, TN-E, and CP, more repeated testing, about 2-3 administrations, or enhancing the practice times may reduce the influence of the practice effect (Bartels, Wegrzyn, Wiedl, Ackermann, & Ehrenreich, 2010) . Clinicians should consider the practice effect when interpreting the test results of their clients. Thus, any difference in scores needs to be greater than the practice effect induced by the measure for true change to be determined. The current study revealed that only the MDC% of TN (29.65%) was smaller than the acceptable criterion (30%) (Chen et al., 2014; Huang et al., 2011) . The results suggested that when the D2 is used in patients with schizophrenia, caution must be taken in explaining the change score in attentional function. According to our results, a score of 103 or higher is needed for a change score of "TN" to be considered real (i.e., beyond measurement error). This score is relatively high as compared with the mean of "TN". In other words, it is very difficult for a patient with schizophrenia to improve a change score by 103 and thereby demonstrate real improvement. For the seven subscores, TN, TN-E, and CP had better random measurement error than the other subscores. Therefore, the TN, TN-E and CP subscores would have better utility in patients with schizophrenia in clinical settings.
Our results reveal that the D2 has acceptable agreement between repeated measurements but large random measurement error in patients with schizophrenia. High standard deviation would be the major cause of high MDC and MDC%. The results implied that the participants in the study had a large range of ability. On the other hand, the participants filled out the D2 as quickly as possible; doing so too fast could result in numerous wrong answers. That is why the MDC and MDC% of E (85.0%), E 1 (94.6%), and E 2 (69.0%) are larger. It also implies that the error scores on the D2 were less reliable in individuals with schizophrenia in particular. The scores of E, E 1 , and E 2 need to be applied carefully in patients with schizophrenia.
Bland-Altman plots can be used to visualize systematic variations around the zero line, the LOA, and to illustrate whether a trend (heteroscedasticity) exists in the sample in a study (Flansbjer, Holmback, Downham, Pattent, & Lexell, 2005) . The presence of heteroscedastic errors in measurements could have practical research implications. The current study revealed that the scores of E1, E2, and E were heteroscedastic. Therefore, a measurement with higher value also entails a greater amount of measurement error.
Other important measures include the reliable change (RC) index. The RC index enables identification of patients whose response to treatment is clinically as well as statistically significant (Christensen & Mendoza, 1986; Jacobson, Follette, & Revenstorf, 1984) . The RC index is calculated by determining the difference between pretest and posttest scores and then dividing this difference by a standard error measure that includes the standard deviation of the measure and the reliability coefficient (Turk, Okifuji, Sinclair, & Terence, 1998) . The reliable change index modified for practice (RCIp) takes the practice effect into account when interpreting the change in scores in an individual patient. An RCIp with a 90% confidence interval (CI) calculates the range of a change score to determine whether the change in an individual patient's scores was beyond random measurement error and practice effect (Koh et al., 2011) . The RC index or RCIp may be used in related research when considering the practice effect in the future.
Different indicators, such as the Ruff 2 and 7 selective attention test (RSAT), are used for assessing cognition in patients with schizophrenia. However, the MDC of the RSAT has not been examined in any other research articles, so the test-retest reliability and MDC of the RSAT will be the topic of future research. Currently, comparisons of different indicators of selective attention in persons with schizophrenia with other studies are limited.
Limitations
The limitation in the research should be addressed. Schizophrenia is a heterogeneous disorder with fluctuating symptom severity, even in stable patients. The CGI-S is used for assessing symptom stability, which might entail a limitation in the study. Notably, most of the participants were scored as mild or borderline on the CGI-S. Thus, the results of the study cannot be generalized to populations with more serious symptoms. The extent of subtle changes in symptoms is a point of concern as a source of variability in assessing test-retest reliability in this sample. In the future, related studies may consider more precise assessment tools for monitoring stability in such patients.
Conclusion
In summary, our results indicated that the D2 has good reliability, especially in the scores of TN, TN-E, and CP, in monitoring the selective attention function of patients with schizophrenia. The MDCs of TN, TN-E, and CP also indicated that those subscores would be better to use in the clinic in patients with schizophrenia. Further research should seek a way to improve the administration procedure to reduce the random measurement error of the E 1 , E 2 , E, and FR subscores. The results of the present study can be used as a reference for the measurement error of the D2 to help clinicians and researchers determine true change between successive assessments of patients with schizophrenia.
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